Skip to main content
. Author manuscript; available in PMC: 2013 Oct 23.
Published in final edited form as: J Neurosurg. 2013 May 10;119(3):10.3171/2013.4.JNS1368. doi: 10.3171/2013.4.JNS1368

TABLE 1.

Patient characteristics—C5 genotypes*

Characteristic A/A (n = 47) A/G (n = 130) G/G (n = 118)
age >75 yrs 23.4% 24.6% 33.9%
yrs of education (mean) 14.4 ± 3.0 14.4 ± 3.4 14.7 ± 3.1
BMI (mean) 26.0 ± 4.2 27.4 ± 4.6 27.4 ± 4.9
history of smoking 78.7% 71.5% 71.2%
hypertension 48.9% 59.2% 58.5%
statin use 72.3% 74.6% 72.9%
diabetes mellitus 19.1% 24.6% 19.5%
PVD 27.7% 29.2% 25.4%
symptomatic 51.1% 50.0% 39.0%
cross-clamp duration in minutes (mean) 43.8 ± 18.1 47.4 ± 16.6 45.2 ± 18.8
CD at 1 day after CEA 40.4% 18.5% 14.4%
CD at 1 month after CEA 16.7% 18.1% 6.8%
white 87.2% 90.8% 92.4%
black 6.4% 3.8% 1.7%
Hispanic 2.1% 1.5% 1.7%
other 4.3% 3.8% 4.2%
*

Values represent percentages of patients unless otherwise indicated. Means are given with SDs.

Abbreviations: BMI = body mass index; PVD = peripheral vascular disease.

Due to previous cerebrovascular accident, stroke, or transient ischemic attack.